Anti-inflammatory Applications of Eucalyptol in Respiratory Health

Eucalyptol, also known as 1,8-cineole, is a naturally occurring monoterpene oxide extracted chiefly from eucalyptus and other aromatic plants. Its pharmacological profile encompasses mucolytic, bronchodilatory and anti-inflammatory activities that have underpinned traditional and modern therapeutic uses in airway disorders such as asthma, chronic obstructive pulmonary disease (COPD), bronchitis and rhinosinusitis. Mechanistically, eucalyptol modulates innate immune signalling by attenuating pro-inflammatory mediators, including tumour necrosis factor-α, interleukins and nitric oxide, through downregulation of transcription factors and kinases such as NF-κB and p38 MAPK. It also interferes with pattern recognition receptor pathways and inflammasome activation, thereby dampening exaggerated inflammatory responses without compromising host defence. Clinically, adjunctive administration has been shown to reduce mucus viscosity, enhance airway clearance and lower exacerbation rates, while its favourable safety profile and compatibility with standard bronchodilators and corticosteroids point to broader applications in chronic respiratory care. Ongoing work seeks to optimise delivery systems and dosage regimens to maximise pulmonary deposition and sustain therapeutic concentrations in the airways.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Anti-inflammatory Applications of Eucalyptol in Respiratory Health publication trend

The graph below shows the total number of articles in anti-inflammatory applications of eucalyptol in respiratory health across all publications each year (not limited to Nature Index journals).

Technical terms

Eucalyptol: A monoterpenoid oxide found in eucalyptus oil, possessing mucolytic, bronchodilatory and anti-inflammatory properties.

NLRP3 inflammasome: A multiprotein cytosolic complex in immune cells that activates caspase-1, leading to maturation and release of interleukin-1β.

NF-κB: A transcription factor central to the regulation of genes encoding pro-inflammatory cytokines, chemokines and adhesion molecules.

Pattern recognition receptors: Innate immune sensors on or within cells that detect pathogen-associated or damage-associated molecular patterns to trigger inflammatory responses.

References

1. 1,8-cineole (eucalyptol): A versatile phytochemical with therapeutic applications across multiple diseases. Biomedicine & Pharmacotherapy (2023).
2. Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial. Respiratory Research (2009).
3. Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFκB. PLOS ONE (2017).